In exciting news for prostate cancer research, our Director of Research Professor Lisa Horvath has been awarded a $1.9 million Investigator grant from the National Health and Medical Research Council. The grant will fund Prof Horvath’s internationally recognised research into new and more effective treatments for prostate cancer.
Prof Horvath’s team are investigating how biomarkers – blood-based molecular markers – can be used to personalise treatment for men with advanced prostate cancer. Her research aims to investigate the ability of biomarkers to predict an individual patient’s response to different treatments, which will lead to the development of more personalised treatments.
“This significant investment can only further strengthen Australia’s reputation as a world leader in cancer research,” says Prof Horvath.
This prestigious grant is a testament not only to the work of Professor Horvath and her team, but to the incredible generosity and vision of donors like you. Your support through last year’s tax appeal provided the funding that was crucial to enabling the early stages of this research and enabled us to leverage further investment for research that will change the lives of patients with cancer.
To learn more about how you can support research at Chris O’Brien Lifehouse, please contact our Development team at email@example.com or on (02) 8514 0006.